---
type: connection
sweep_date: 2026-05-14
sweep_sha: 81e6264
section_index: 2
global_index: 2
pass3_verdict: Confirmed
overlap_tag: EXTENSION
---

# The quantification ladder closes the loop between personal pharmacogenomics and home-quantified intervention — enabling a genotype-informed, dose-verified n=1 protocol that the wiki currently lacks as a named workflow.

2. **The quantification ladder closes the loop between personal pharmacogenomics and home-quantified intervention — enabling a genotype-informed, dose-verified n=1 protocol that the wiki currently lacks as a named workflow.** *Supported.* `[CHAIN-DEPTH: 2]` `[PHASE-A-MATCH: no]`
   - *Documents Connected:* `personal-genome-protocol.md`, `quantification-ladder.md`, `enzyme-quantification-protocol.md`, `medicinal-mushroom-extract-sops.md`, `self-experiment-protocol.md`, `t-axis-adjuvant-urate-mapping-computational.md`
   - *Page-pair linkage:* `personal-genome-protocol.md` ↔ `quantification-ladder.md` are not cross-referenced. `personal-genome-protocol.md` links to `self-experiment-protocol.md` and `abcg2-modulators.md`; `quantification-ladder.md` links to `enzyme-quantification-protocol.md` and `medicinal-mushroom-extract-sops.md`. The two clusters are disconnected.
   - *Why It Matters:* The personal-genome-protocol.md enables genotype-informed supplement selection (e.g., ABCG2 Q141K → butyrate emphasis; URAT1 gain-of-function → cordycepin over eurycomanone per comp-015 v2). The quantification-ladder.md enables home quantification of those supplements (e.g., Tier 2 colorimetric cordycepin, Tier 2 Ellman’s for ergothioneine). Together they form a **closed-loop n=1 pharmacogenomics workflow**: genotype → compound selection → home production → Tier 2 batch QC → calibrated dosing → biomarker tracking. No existing wiki page names this workflow. The self-experiment-protocol.md currently treats supplement dosing as a fixed-input variable; the quantification ladder makes it a verified variable.
   - *Suggested Action:* Add a “Genotype-informed supplement quantification” subsection to `self-experiment-protocol.md` that references both `personal-genome-protocol.md` and `quantification-ladder.md`, with a worked example (e.g., Q141K-positive → butyrate/fermentable fiber emphasis → Tier 2 SCFA or indirect readout). Also, add the missing cross-reference from `personal-genome-protocol.md` to `quantification-ladder.md`.

> **Pass 3 review — Confirmed.** `[OVERLAP: RESTATEMENT]` The connection survives verification: `personal-genome-protocol.md` contains genotype-stratified supplement/adjuvant selection logic, while `quantification-ladder.md` defines the calibrate-once-at-Tier-3 / track-batches-cheap operational pattern, and `self-experiment-protocol.md` currently requires dose/form/timing to be specified but does not name a genotype-informed quantification workflow. The proposed cross-reference is therefore not a restatement; it composes two disconnected operational clusters into a closed-loop n=1 workflow.

---

## ✓ Actioned 2026-05-15

The connection composed two disconnected operational clusters into a named workflow. Shipped both edits Pass 2 + Pass 3 recommended:

**Files shipped:**

- **`wiki/self-experiment-protocol.md` §12 (new)** — "Genotype-informed supplement quantification workflow." Names the closed-loop n=1 pharmacogenomics composition: genotype → compound selection → home production → Tier 2 batch QC → calibrated dose → biomarker tracking. Five-step workflow detailed in §12.1; worked example for Q141K-positive carrier + butyrate-emphasis stack in §12.2; open follow-ups (Tier 3 anchor library consolidation, H09 dependency on home-production reliability) in §12.3. Honors the `user_brian_no_consumer_genetic_testing` memory by leading with clinical-grade panels and explicitly not recommending consumer panels.
- **`wiki/personal-genome-protocol.md` §See also** — extended with cross-references to `self-experiment-protocol.md` §12 (the workflow it now composes with), `quantification-ladder.md` (its sister operational page), `enzyme-quantification-protocol.md`, and `medicinal-mushroom-extract-sops.md`. The §12 pointer makes the closed-loop framing discoverable from the genotyping-entry page.

**What the worked example does NOT claim** (Pass 3 discipline preserved):
- NOT that butyrate alone produces clinically meaningful ΔSUA (gated by H08 + absence of typical-gout Phase 2b RCT)
- NOT that the SCFA stool readout is mechanistically equivalent to a direct potency assay — it's an indirect proxy
- DOES illustrate the workflow shape: every link in the chain is verified rather than assumed

**Cross-link parity:** the reverse pointer from `quantification-ladder.md` back to `personal-genome-protocol.md` is a candidate for the next quantification-ladder edit. Surfaced as an open follow-up in §12.3 rather than actioned here (low priority — `personal-genome-protocol.md` now points at quantification-ladder.md, so the parity gap is one-directional and minor).

The composition is now named. Closing.
